Elevated Levels of miR-155 in Blood and Urine from Patients with Nephrolithiasis
Background. Both circulating and urinary miRNAs may represent a potential noninvasive molecular biomarker capable of predicting chronic kidney disease, and, in the present study, we will investigate the serum and urinary levels of miR-155 in patients with nephrolithiasis. Methods. Serum and urinary...
Main Authors: | Yang-Yang Hu, Wei-Da Dong, Yun-Fei Xu, Xu-Dong Yao, Bo Peng, Min Liu, Jun-Hua Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/295651 |
Similar Items
-
Elevated Levels of miR-146a and miR-155 in Kidney Biopsy and Urine from Patients with IgA Nephropathy
by: Gang Wang, et al.
Published: (2011-01-01) -
Urinary Angiotensinogen Is Elevated in Patients with Nephrolithiasis
by: Wei Sun, et al.
Published: (2014-01-01) -
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
by: Sven H Loosen, et al.
Published: (2019-01-01) -
Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis.
by: Bogdan Kolarz, et al.
Published: (2020-01-01) -
miR-155 in the Resolution of Atherosclerosis
by: Robyn Bruen, et al.
Published: (2019-05-01)